
AI-hallucinated citations are creeping into papers that shape clinical guidelines, researchers warn
Quick Take
An audit of 2.5 million biomedical papers reveals a twelvefold increase in AI-generated fake citations since 2023, likely linked to language model usage. 98% of affected papers have not received publisher responses, raising concerns about the integrity of clinical guidelines.
Key Points
- The rate of fabricated references in biomedical papers has surged over 1200% since 2023.
- AI-generated citations often match paper topics and are formatted correctly, making them hard to detect.
- Columbia University conducted the audit alongside other institutions, examining 2.5 million papers.
- 98% of the papers with fake citations have not received any response from publishers.
- Concerns are rising about the impact of these citations on clinical guidelines.
Article Excerpt
From source RSS / original summaryAn audit of 2. 5 million biomedical papers by Columbia University and other institutions shows that the rate of fabricated references has increased more than twelvefold since 2023. The researchers suspect a link to the widespread use of language models - the fake references match their paper's topic, follow correct formatting, and are nearly impossible to spot. 98 percent of the affected papers have received no response from their publishers.
The article AI-hallucinated citations are creeping into papers that shape clinical guidelines, researchers warn appeared first on The Decoder.
Reader Mode unavailable (could not extract clean content).
Want this in your inbox every morning?
Daily brief at your local 8am — bilingual EN/中文, free.
More from The Decoder
See more →
Microsoft and Nvidia reportedly team up on AI PCs that run actual agents instead of Copilot
Nvidia is entering the PC market with its own chips, debuting Windows PCs from Dell and Microsoft's Surface line at Computex and Build. Microsoft plans to introduce new software based on the OpenClaw framework, enabling AI agents to perform tasks locally, marking a pivot from the unsuccessful Copilot+ concept.


